BFW 08/28 18:27 *BAXALTA SAID IN TALKS TO BUY ARIAD TO BOOST ONCOLOGY OFFERINGS
BN 08/28 18:26 *TALKS WITH ARIAD SAID TO CONTINUE, MAY NOT RESULT IN DEAL
BN 08/28 18:26 *BAXALTA SAID IN TALKS TO BUY ARIAD TO BOOST ONCOLOGY OFFERINGS
BN 08/28 18:26 *TALKS WITH ARIAD SAID TO CONTINUE, MAY NOT RESULT IN DEAL
BN 08/28 18:26 *BAXALTA SAID IN TALKS TO BUY ARIAD TO BOOST ONCOLOGY OFFERINGS
Baxalta Said in Talks to Buy Ariad to Boost Oncology Offerings
2015-08-28 18:28:29.351 GMT
By Catherine Larkin
(Bloomberg) -- Talks with Ariad said to continue, may not
result in deal.
* ARIA up as much as 38%
* NOTE: Earlier, Ariad Pharma Gains; Baxalta Said to Pursue
Unidentified Co. Link
Link to Company News:{ARIA US <Equity> CN <GO>}
Link to Company News:{BXLT US <Equity> CN <GO>}
Link to Company News:{SHP LN <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the editor responsible for this story:
Catherine Larkin at +1-312-443-5968 or
clarkin4@bloomberg.net
2015-08-28 18:28:29.351 GMT
By Catherine Larkin
(Bloomberg) -- Talks with Ariad said to continue, may not
result in deal.
* ARIA up as much as 38%
* NOTE: Earlier, Ariad Pharma Gains; Baxalta Said to Pursue
Unidentified Co. Link
Link to Company News:{ARIA US <Equity> CN <GO>}
Link to Company News:{BXLT US <Equity> CN <GO>}
Link to Company News:{SHP LN <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the editor responsible for this story:
Catherine Larkin at +1-312-443-5968 or
clarkin4@bloomberg.net